Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1723-1734

  Negus, Rupert P M ^a,c   Stamp, Gordon W H ^a   Hadley, Joanna ^b   Balkwill, Frances R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c Imperial Cancer Research Fund   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

ARTICLE; CELL INFILTRATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE MIGRATION; NATURAL KILLER CELL; OVARY CANCER; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030944928     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Svennevig JL, Svaar H: Content and distribution of macrophages and lymphocytes in solid malignant human tumours. Int J Cancer 1979, 24:754-758
2. Tang R, Beuvon F, Ojeda M, Mosseri V, Pouillart P, Scholl S: M-CSF (monocyte colony stimulating factor), and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes? J Cell Biochem 1992, 50:350-356
3. Dietl J, Horny HP, Ruck P, Kaiserling E: Dysgerminoma of the ovary: an immunohistochemical study of tumor-infiltrating iymphoreticular cells and tumor cells. Cancer 1993, 71:2562-2568
4. Herrmann G, Schumm Draeger PM, Muller C, Atai E, Wenzel B, Fabian T, Usadel KH, Hubner K: T lymphocytes, CD68-positive cells, and vascularisation in thyroid carcinomas. J Cancer Res Clin Oncol 1994, 120: 651-656
5. Banner BF, Savas L, Baker S, Woda BA: Characteriza- tion of the inflammatory cell populations in normal colon and colonie carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1993, 64:213-220
6. Haskill S, Becker S, Fowler W, Walton L: Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br J Cancer 1982, 45:728-736
7. Kabawat SE, Bast RC Jr, Welch WR, Knapp RC, Bhan AK: Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms. Int J Cancer 1983, 32:547-554
8. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 1992, 13:265-270
9. Mantovani A: Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 1994, 71:5-16
10. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV: Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994, 91: 12808-12812
11. Fidler IJ, Schroit AJ: Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. J Immunol 1984, 133: 515-518
12. Mantovani A: In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases. Int J Cancer 1981, 27:221-228
13. Rollins BJ, Sunday ME: Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol Cell Biol 1991, 11:3125-3131
14. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995, 92:4392-4396
15. Negus RP, Stamp GW, Reif MG, Burke F, Malik ST, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR: The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 1995, 95:2391-2396
16. Takeshima H, Kuratsu J, Takeya M, Yoshimura T, Ushio Y: Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J Neurosurg 1994, 80:1056-1062
17. Foulkes WD, Ragoussis J, Stamp GW, Allan GJ, Trowsdale J: Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer 1993, 67:551-559
18. Curtis ASG: Area and volume measurements by random sampling methods. Med Biol Illustrated 1960, 10: 261-266
19. DeHoff RT, Rhines FN: Determination of the number of particles per unit volume from measurements made on random plane sections: the general cylinder and ellipsoid. Trans Am Inst Mining Metallurg Eng 1961, 221:975
20. Aherne WA, Dunhill MS: Morphometry. London, Arnold, 1982
21. Altman DG: Practical statistics for medical research. London, Chapman and Hall, 1991
22. Bland JM, Altman DG: Multiple significance tests: the Bonferroni method. Br Med J 1995, 310:170
23. + macrophages in antitumor cytotoxicity. Lab Invest 1992, 67:166-174
24. Lwin KY, Zuccarini O, Sloane JP, Beverley PC: An immunohistological study of leukocyte localization in benign and malignant breast tissue. Int J Cancer 1985, 36:433-438
25. Svennevig JL, Lovik M, Svaar H: Isolation and characterization of lymphocytes and macrophages from solid, malignant human tumours. Int J Cancer 1979, 23: 626-631
26. Fidler IJ: Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res 1985, 45: 4714-4726
27. Apiranthitou Drogari M, Paganin C, Bernasconi S, Losa G, Maneo A, Colombo N, Mantovani A, Allavena P: In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma. Cancer Immunol Immunother 1992, 35:289-295
28. Burke F, Reif M, Negus R, Balkwill F: A cytokine profile of normal and malignant ovary. Cytokine 1996, 8: 578-585
29. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α, and MIP-1β on human monocytes, Eur J Immunol 1995, 25:64-68
30. Roth SJ, Carr MW, Springer TA: C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol 1995, 25:3482-3488
31. + T lymphocytes. FASEB J 1994, 8:1055-1060
32. + T cells in response to MIP-1α and MIP-1β, Science 1993, 260:355-358
33. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV: Human macrophage inflammatory protein α (MIP-1α) and MIP-1β chemokines attract distinct populations of lymphocytes. J Exp Med 1993, 177:1821-1826
34. Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990, 347:669-671
35. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8, and RANTES. Eur J Immunol 1995, 25:751-756
36. Kawasaki ES, Ladner MB, Wang AM, Van Arsdell J, Warren MK, Coyne MY, Schweickart VL, Lee MT, Wilson KJ, Boosman A, Stanley ER, Ralph P, Mark DF: Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985, 230:291-296
37. Wang JM, Griffin JD, Rambaldi A, Chen ZG, Mantovani A: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 1988, 141:575-579
38. Baccarini M, Kiderlen AF, Decker T, Lohmann Matthes ML: Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrow. Cell Immunol 1986, 101:339-350
39. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohrschneider L, Tang R, Pouillart P, Lidereau R: Anticolony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 1994, 86:120-126
40. Kacinski BM, Carter D, Mittal K, Yee LD, Scata KA, Donofrio L, Chambers SK, Wang KI, Yang Feng T, Rohrschneider LR, Rothwell V: Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am J Pathol 1990, 137:135-147
41. Kacinski BM: CSF-1 and its receptor in ovarian, endometrial, and breast cancer. Ann Med 1995, 27:79-85
42. Naylor MS, Stamp GW, Foulkes WD, Ecoles D, Balkwill FR: Tumor necrosis factor and its receptors in human ovarian cancer: potential role in disease progression. J Clin Invest 1993, 91:2194-2206